Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - OPERATING EXPENSES
Operating Expenses AKBA - Akebia Therapeutics, Inc.
167 M
LAST VALUE
-28.43%
2 YEAR CAGR
-15.11%
5 YEAR CAGR
26.47%
10 YEAR CAGR